Neovasc Inc. NVCN

Healthcare Medical Instruments & Supplies

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

NDAQ:NVCN - Post by User

Neovasc Inc. > The split is on the table

<< Previous

Bullboard Posts

Next >>

Comment by Barewoodon May 23, 2018 11:59am

102 Views

Post# 28069827

RE:RE:RE:RE:RE:RE:RE:RE:The split is on the table

Montrose9 wrote: Just remember its hard to make money in stocks where the shareholder base are underwater. If a share compression of 1 for 100 takes place as the news release underscores then somebody with a cost of 2 dollars per share then has a cost of 200 dollars per share

That is not how it works.

<< Previous

Bullboard Posts

Next >>

Canopy Growth nears adjusted EBITDA profitability in Q2 2025